Evidence map›Paper›PMID 34918368›Full record

Trial reportMuscle & nerve2022

Characterization of patients with Becker muscular dystrophy by histology, magnetic resonance imaging, function, and strength assessments.

Giacomo P Comi, Erik H Niks, Claudia M Cinnante, Hermien E Kan, Krista Vandenborne, Rebecca J Willcocks, Daniele Velardo, Michela Ripolone, Jules J van Benthem, Nienke M van de Velde and 4 more

2 registry-linked trialsOpen access · hybridAbstract readClinical Trial, Phase II
In one paragraph

Trial report in Muscle & nerve, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05618080 active not recruitingnot on this mapstarted 2024, after this paper: background citation

GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1

TypeobservationalSponsorVirginia Commonwealth UniversityRan2024 to 2028Enrolled100ConditionsCalpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A, Limb Girdle Muscular Dystrophy, Limb Girdle Muscular Dystrophy Type R1, LGMD2A
NCT05989620 recruitingnot on this mapstarted 2023, after this paper: background citation

Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)

TypeobservationalSponsorVirginia Commonwealth UniversityRan2023 to 2029Enrolled1,000ConditionsLGMD1B, LGMD1C, LGMD1D, LGMD1E
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. MicroRNAs as serum biomarkers in Becker muscular dystrophy.Journal of cellular and molecular medicine · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Giacomo P ComiNeuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Erik H NiksDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Claudia M CinnanteNeuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Hermien E KanDuchenne Center Netherlands, The Netherlands.
Krista VandenborneImagingDMD and Department of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Rebecca J WillcocksImagingDMD and Department of Physical Therapy, University of Florida, Gainesville, Florida, USA.
Daniele VelardoNeuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Michela RipoloneNeuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Jules J van BenthemDepartment of Orthopedics, Rehabilitation and Physiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
Nienke M van de VeldeDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Simone NavaNeuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Laura AmbrosoliOPIS srl, Milan, Italy.
Sara CazzanigaItalfarmaco SpA, Milan, Italy.
Paolo U BetticaItalfarmaco SpA, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITLeiden University Medical Center · NLItalfarmaco (Italy) · ITDuchenne Parent Project · NLFondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica · ITUniversity of Florida · USUniversity of Florida Health · US

Funding

Magnetic Resonance Imaging and Biomarkers for Muscular DystropyR01AR056973 · NIAMS · UNIVERSITY OF FLORIDA · PI VANDENBORNE, KRISTA H · 2010 to 2024
$20.2M
NIAMS NIH HHS R01 AR056973
6 · The paper itself

Abstract

INTRODUCTION/

aimsBecker muscular dystrophy (BMD) is characterized by variable disease severity and progression, prompting the identification of biomarkers for clinical trials. We used data from an ongoing phase II study to provide a comprehensive characterization of a cohort of patients with BMD, and to assess correlations between histological and magnetic resonance imaging (MRI) markers with muscle function and strength.

methodsEligible patients were ambulatory males with BMD, aged 18 to 65 years (200 to 450 meters on 6-minute walk test). The following data were obtained: function test results, strength, fat-fraction quantification using chemical shift-encoded MRI (whole thigh and quadriceps), and fibrosis and muscle fiber area (MFA) of the brachial biceps.

resultsOf 70 patients screened, 51 entered the study. There was substantial heterogeneity between patients in muscle morphology (histology and MRI), with high fat replacement. Total fibrosis correlated significantly and mostly moderately with all functional endpoints, including both upper arm strength assessments (left and right elbow flexion rho -.574 and -.588, respectively [both P < .0001]), as did MRI fat fraction (whole thigh and quadriceps), for example, with four-stair-climb velocity -.554 and -.550, respectively (both P < .0001). Total fibrosis correlated significantly and moderately with both MRI fat fraction assessments (.500 [P = .0003] and .423 [.0024], respectively). DISCUSSION: In this BMD cohort, micro- and macroscopic morphological muscle parameters correlated moderately with each other and with functional parameters, potentially supporting the use of MRI fat fraction and histology as surrogate outcome measures in patients with BMD, although additional research is required to validate this.

Indexed as

Muscular Dystrophy, DuchenneAdolescentAdultAgedHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleMiddle AgedMuscle, SkeletalThighYoung AdultBecker muscular dystrophycorrelationfunctionhistologymagnetic resonance imaging

Identifiers

PMID34918368
PMCPMC9302983
OpenAlexW4200382179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.